U.S Physical Therapy Debt to Equity Ratio 2010-2025 | USPH
Current and historical debt to equity ratio values for U.S Physical Therapy (USPH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. U.S Physical Therapy debt/equity for the three months ending March 31, 2025 was 0.32.
| U.S Physical Therapy Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2025-03-31 |
$0.68B |
$0.50B |
1.36 |
| 2024-12-31 |
$0.68B |
$0.49B |
1.38 |
| 2024-09-30 |
$0.55B |
$0.48B |
1.13 |
| 2024-06-30 |
$0.54B |
$0.49B |
1.11 |
| 2024-03-31 |
$0.54B |
$0.48B |
1.11 |
| 2023-12-31 |
$0.52B |
$0.48B |
1.09 |
| 2023-09-30 |
$0.52B |
$0.49B |
1.05 |
| 2023-06-30 |
$0.51B |
$0.49B |
1.04 |
| 2023-03-31 |
$0.55B |
$0.32B |
1.72 |
| 2022-12-31 |
$0.54B |
$0.32B |
1.71 |
| 2022-09-30 |
$0.48B |
$0.32B |
1.51 |
| 2022-06-30 |
$0.49B |
$0.31B |
1.58 |
| 2022-03-31 |
$0.46B |
$0.30B |
1.53 |
| 2021-12-31 |
$0.45B |
$0.30B |
1.52 |
| 2021-09-30 |
$0.34B |
$0.29B |
1.17 |
| 2021-06-30 |
$0.34B |
$0.29B |
1.19 |
| 2021-03-31 |
$0.32B |
$0.28B |
1.16 |
| 2020-12-31 |
$0.32B |
$0.28B |
1.14 |
| 2020-09-30 |
$0.31B |
$0.27B |
1.16 |
| 2020-06-30 |
$0.33B |
$0.26B |
1.28 |
| 2020-03-31 |
$0.40B |
$0.24B |
1.66 |
| 2019-12-31 |
$0.32B |
$0.24B |
1.32 |
| 2019-09-30 |
$0.33B |
$0.24B |
1.38 |
| 2019-06-30 |
$0.33B |
$0.23B |
1.41 |
| 2019-03-31 |
$0.30B |
$0.22B |
1.37 |
| 2018-12-31 |
$0.23B |
$0.22B |
1.04 |
| 2018-09-30 |
$0.24B |
$0.21B |
1.14 |
| 2018-06-30 |
$0.23B |
$0.21B |
1.07 |
| 2018-03-31 |
$0.21B |
$0.21B |
1.00 |
| 2017-12-31 |
$0.21B |
$0.21B |
1.03 |
| 2017-09-30 |
$0.21B |
$0.20B |
1.06 |
| 2017-06-30 |
$0.22B |
$0.20B |
1.13 |
| 2017-03-31 |
$0.20B |
$0.19B |
1.01 |
| 2016-12-31 |
$0.16B |
$0.19B |
0.86 |
| 2016-09-30 |
$0.09B |
$0.22B |
0.42 |
| 2016-06-30 |
$0.10B |
$0.21B |
0.46 |
| 2016-03-31 |
$0.10B |
$0.21B |
0.49 |
| 2015-12-31 |
$0.13B |
$0.17B |
0.76 |
| 2015-09-30 |
$0.09B |
$0.19B |
0.48 |
| 2015-06-30 |
$0.09B |
$0.18B |
0.47 |
| 2015-03-31 |
$0.08B |
$0.18B |
0.46 |
| 2014-12-31 |
$0.08B |
$0.17B |
0.46 |
| 2014-09-30 |
$0.09B |
$0.16B |
0.52 |
| 2014-06-30 |
$0.08B |
$0.16B |
0.47 |
| 2014-03-31 |
$0.07B |
$0.15B |
0.48 |
| 2013-12-31 |
$0.07B |
$0.15B |
0.48 |
| 2013-09-30 |
$0.03B |
$0.15B |
0.23 |
| 2013-06-30 |
$0.04B |
$0.15B |
0.24 |
| 2013-03-31 |
$0.04B |
$0.14B |
0.27 |
| 2012-12-31 |
$0.04B |
$0.14B |
0.28 |
| 2012-09-30 |
$0.03B |
$0.14B |
0.25 |
| 2012-06-30 |
$0.04B |
$0.13B |
0.29 |
| 2012-03-31 |
$0.04B |
$0.13B |
0.31 |
| 2011-12-31 |
$0.04B |
$0.12B |
0.34 |
| 2011-09-30 |
$0.04B |
$0.12B |
0.34 |
| 2011-06-30 |
$0.03B |
$0.12B |
0.28 |
| 2011-03-31 |
$0.03B |
$0.11B |
0.30 |
| 2010-12-31 |
$0.02B |
$0.12B |
0.21 |
| 2010-09-30 |
$0.02B |
$0.11B |
0.19 |
| 2010-06-30 |
$0.02B |
$0.10B |
0.20 |
| 2010-03-31 |
$0.03B |
$0.10B |
0.30 |
| 2009-12-31 |
$0.02B |
$0.09B |
0.21 |
| 2009-09-30 |
$0.02B |
$0.09B |
0.24 |
| 2009-06-30 |
$0.03B |
$0.09B |
0.31 |
| 2009-03-31 |
$0.03B |
$0.09B |
0.36 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$1.124B |
$0.671B |
|
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
|
